COVID Vaccine Initiative


The COVID Vaccine Initiative (CVI) aims to ensure the development of safe, effective, and accessible vaccines for those most vulnerable to COVID-19: aging populations and those living in low- and middle-income countries. It leverages HVP’s global clinical research consortium, including newly established collaborations with the Harvard T.H. Chan School of Public Health focused on deciphering effective immunity in aging populations; FHI 360, a global nonprofit research and human development organization with extensive experience working in low and middle-income countries; and the University of Minnesota’s Center for Infectious Disease Research and Policy, a global leader in addressing public health preparedness and emerging infectious disease response.

COVID Newsroom

Global COVID Lab Meeting

May 06, 2021

Laura M. Walker

Adimab & Adagia Therapeutics

Global COVID Lab Meeting

Apr 22, 2021

Nir Barzilai, M.D.

Albert Einstein College of Medicine

Global COVID Lab Meeting

Apr 08, 2021

Petter Brodin, M.D., Ph.D.

Karolinska Institute

Global COVID Lab Meeting

Mar 25, 2021

Penny Moore, Ph.D.

The National Institute for Communicable Diseases

Global COVID Lab Meeting

Mar 11, 2021

Sean Tucker, Ph.D., P.E.

Vaxart, Inc.